NASDAQ:NVOS

Novo Integrated Sciences Stock Forecast, Price & News

$2.03
-0.06 (-2.87 %)
(As of 07/23/2021 03:01 PM ET)
Add
Compare
Today's Range
$2.03
$2.04
50-Day Range
$2.09
$2.75
52-Week Range
$1.95
$14.98
Volume1,706 shs
Average Volume214,126 shs
Market Capitalization$53.77 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NVOS News and Ratings via Email

Sign-up to receive the latest news and ratings for Novo Integrated Sciences and its competitors with MarketBeat's FREE daily newsletter.


About Novo Integrated Sciences

Novo Integrated Sciences, Inc., together with its subsidiaries, provides primary healthcare services. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers specialty treatment and recovery programs derived from motor vehicle accident injuries, long-term disability cases, corporate wellness, and job-site injuries. Further, it provides cold laser therapeutics, shockwave therapy, custom bracing and orthotics, custom compression therapy/stockings, and lymphatic drainage treatment. The company offers medical technology services, such as telemedicine and remote patient monitoring. It operates 16 owned clinics, a contracted network of 102 affiliate clinics, and 220 eldercare related care homes, as well as retirement homes and community-based locations in Canada. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

2181st out of 2,216 stocks

Engines & Turbines Industry

19th out of 19 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Novo Integrated Sciences (NASDAQ:NVOS) Frequently Asked Questions

What stocks does MarketBeat like better than Novo Integrated Sciences?

Wall Street analysts have given Novo Integrated Sciences a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novo Integrated Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Novo Integrated Sciences' next earnings date?

Novo Integrated Sciences is scheduled to release its next quarterly earnings announcement on Friday, July 23rd 2021.
View our earnings forecast for Novo Integrated Sciences
.

What guidance has Novo Integrated Sciences issued on next quarter's earnings?

Novo Integrated Sciences issued an update on its second quarter 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $2.08 million-$2.08 million.

Who are Novo Integrated Sciences' key executives?

Novo Integrated Sciences' management team includes the following people:
  • Mr. Robert Mattacchione, Chairman & CEO (Age 52)
  • Mr. Christopher Mehlin David, Pres & Director (Age 62, Pay $96k)
  • Mr. James Zsebok, Principal Financial Officer & Principal Accounting Officer (Age 55)
  • Mr. David Brien BSc.PT, BSc.Bio, Sr. VP of Clinical Operations - Eastern Ontario
  • Ms. Emily Mattacchione, Treasurer (Age 40)
  • Mr. Michael Joseph Gaynor BScPT, FCAMPT, MCPA, Sec. & Director (Age 54)
  • Mr. James Asher, Pres of Novo Healthnet Limited

Who are some of Novo Integrated Sciences' key competitors?

What is Novo Integrated Sciences' stock symbol?

Novo Integrated Sciences trades on the NASDAQ under the ticker symbol "NVOS."

How do I buy shares of Novo Integrated Sciences?

Shares of NVOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novo Integrated Sciences' stock price today?

One share of NVOS stock can currently be purchased for approximately $2.03.

How much money does Novo Integrated Sciences make?

Novo Integrated Sciences has a market capitalization of $53.77 million.

How many employees does Novo Integrated Sciences have?

Novo Integrated Sciences employs 78 workers across the globe.

What is Novo Integrated Sciences' official website?

The official website for Novo Integrated Sciences is novointegrated.com.

Where are Novo Integrated Sciences' headquarters?

Novo Integrated Sciences is headquartered at 11120 NE 2ND STREET SUITE 100, BELLEVUE WA, 98004.

How can I contact Novo Integrated Sciences?

Novo Integrated Sciences' mailing address is 11120 NE 2ND STREET SUITE 100, BELLEVUE WA, 98004. The company can be reached via phone at 206 617 9797 or via email at [email protected]


This page was last updated on 7/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.